AAIC Advancements: Modernizing Diagnosis

About the Conference

AAIC® Advancements: Modernizing Diagnosis featured global perspectives on the science of Alzheimer’s diagnosis, detection and monitoring. Areas of focus included the Revised Criteria for Diagnosis and Staging of Alzheimer’s Disease, Treatment-Related Amyloid Clearance (TRAC), biomarker advancements, clinical case studies and more.

As science advances and evolves, so do approaches to describing and diagnosing Alzheimer's disease. In particular, we now have a better understanding of the changes in Alzheimer's biomarkers throughout the course of the disease. The global research community met to discuss geographic-specific implications and considerations.

View the 2024 conference program.

Research Themes

All were invited to submit abstracts on the latest research in Alzheimer's diagnosis, detection and monitoring. Abstract themes aligned with Scientific Sessions, including:

• The Landscape for Diagnosis in Asia.
• Revised Criteria for Diagnosis and Staging.
• The Interplay and Integration of Biomarkers: Core Biomarkers and Co-Pathologies.
• Can Blood Tests Stand Alone in Alzheimer’s Disease Diagnosis?
• Implications of Amyloid-Lowering Treatments.
• Towards Earlier Diagnoses: Ethics and Opportunities for Secondary Prevention.
• Real-World Applications – Case Studies.

Scientific Program Committee

• Takeshi Iwatsubo, Chair
• Reisa Sperling, Chair
• Anna Barron
• Seong-Hye Choi
• Takeshi Ikeuchi
• Atsushi Iwata
• Clifford Jack
• Jianping Jia
• Renaud La Joie
• Rema Raman
• Huali Wang

Sponsors

Companies interested in sponsoring future conferences can contact the corporate initiatives team at corporateinitiatives@alz.org.

Appropriate Conduct Policy

AAIC Advancements: Modernizing Diagnosis aims to provide a safe, equitable, and accessible experience for all conference participants.

Read the full Statement of Appropriate Conduct (PDF).

Contact

General questions: aaicadvancements@alz.org
Media questions: media@alz.org